Geode Capital Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.4M | Sell |
2,252,420
-42,611
| -2% | -$215K | ﹤0.01% | 2276 |
|
2025
Q1 | $14.9M | Buy |
2,295,031
+98,430
| +4% | +$638K | ﹤0.01% | 2062 |
|
2024
Q4 | $16.1M | Buy |
2,196,601
+7,827
| +0.4% | +$57.5K | ﹤0.01% | 2073 |
|
2024
Q3 | $16.4M | Buy |
2,188,774
+5,146
| +0.2% | +$38.5K | ﹤0.01% | 2088 |
|
2024
Q2 | $19.4M | Buy |
2,183,628
+234,439
| +12% | +$2.09M | ﹤0.01% | 1939 |
|
2024
Q1 | $19.7M | Buy |
1,949,189
+62,793
| +3% | +$636K | ﹤0.01% | 1937 |
|
2023
Q4 | $19M | Buy |
1,886,396
+92,532
| +5% | +$931K | ﹤0.01% | 1954 |
|
2023
Q3 | $16.8M | Buy |
1,793,864
+103,087
| +6% | +$966K | ﹤0.01% | 1939 |
|
2023
Q2 | $41.5M | Buy |
1,690,777
+165,359
| +11% | +$4.06M | ﹤0.01% | 1379 |
|
2023
Q1 | $35.5M | Buy |
1,525,418
+59,140
| +4% | +$1.38M | ﹤0.01% | 1426 |
|
2022
Q4 | $37.1M | Buy |
1,466,278
+50,049
| +4% | +$1.27M | 0.01% | 1357 |
|
2022
Q3 | $27.3M | Buy |
1,416,229
+37,360
| +3% | +$720K | ﹤0.01% | 1520 |
|
2022
Q2 | $35.1M | Buy |
1,378,869
+133,478
| +11% | +$3.4M | 0.01% | 1360 |
|
2022
Q1 | $32M | Buy |
1,245,391
+13,571
| +1% | +$349K | ﹤0.01% | 1568 |
|
2021
Q4 | $51.6M | Buy |
1,231,820
+36,062
| +3% | +$1.51M | 0.01% | 1286 |
|
2021
Q3 | $52M | Buy |
1,195,758
+28,418
| +2% | +$1.24M | 0.01% | 1240 |
|
2021
Q2 | $55.2M | Buy |
1,167,340
+89,918
| +8% | +$4.25M | 0.01% | 1216 |
|
2021
Q1 | $55.2M | Buy |
1,077,422
+111,047
| +11% | +$5.69M | 0.01% | 1147 |
|
2020
Q4 | $25.9M | Buy |
966,375
+52,065
| +6% | +$1.39M | ﹤0.01% | 1552 |
|
2020
Q3 | $31.4M | Buy |
914,310
+524,887
| +135% | +$18M | 0.01% | 1192 |
|
2020
Q2 | $16M | Buy |
389,423
+273,143
| +235% | +$11.2M | ﹤0.01% | 1653 |
|
2020
Q1 | $3.98M | Buy |
116,280
+81,001
| +230% | +$2.78M | ﹤0.01% | 2271 |
|
2019
Q4 | $443K | Buy |
+35,279
| New | +$443K | ﹤0.01% | 3541 |
|